RecruitingPhase 2NCT07047144
A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
Studying Autosomal dominant adult-onset proximal spinal muscular atrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Scholar Rock, Inc.
- Intervention
- Apitegromab(drug)
- Enrollment
- 52 enrolled
- Eligibility
- 2 years · All sexes
- Timeline
- 2025 – 2029
Study locations (23)
- Phoenix Children's Hospital, Phoenix, Arizona, United States
- Children's Hospital of Orange County (CHOC), Orange, California, United States
- Stanford Neuroscience Health Center (SNHC), Palo Alto, California, United States
- Children's Hospital Colorado, Aurora, Colorado, United States
- University of Iowa, Iowa City, Iowa, United States
- Helen DeVos Children's Hospital at Spectrum Health, Grand Rapids, Michigan, United States
- Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina, United States
- The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
- Le Bonheur Children's Hospital, Memphis, Tennessee, United States
- University of Texas Southwestern Medical Center, Dallas, Texas, United States
- Neurology Rare Disease Center, Flower Mound, Texas, United States
- Cook Children's Medical Center, Fort Worth, Texas, United States
- Texas Children's Hospital (TCH)-Clinical Care Center (CCC), Houston, Texas, United States
- UZ Gent, Ghent, East-Flanders, Belgium
- UZ Leuven - Campus Gasthuisberg, Leuven, Belgium
- +8 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07047144 on ClinicalTrials.govOther trials for Autosomal dominant adult-onset proximal spinal muscular atrophy
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07521930Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)Johns Hopkins University
- ACTIVE NOT RECRUITINGNANCT07547189Effects of Developmental Support for Mothers of Infants With Spinal Muscular AtrophyMedipol University
- RECRUITINGPHASE3NCT07444476A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety in Participants Aged 15 to 60 Years With Spinal Muscular Atrophy (SMA) Who Are Either New to SMA Treatment or Were Previously Treated With RisdiplamBiogen
- RECRUITINGNCT07321990Study of the Reproducibility of the French Version of the Modified SMAFRS ScaleInstitut de Myologie, France
- ACTIVE NOT RECRUITINGNANCT06419322Acceptability, Feasibility, Safety and Efficacy of a Optimized Rehabilitation Program for Treated Patients With Spinal Muscular Atrophy (SMA).University of Oxford
- ACTIVE NOT RECRUITINGNANCT06300996Spinal Cord Stimulation for the Treatment of Motor Deficits in People With Spinal Muscular Atrophy - Upper LimbMarco Capogrosso
- RECRUITINGNANCT06322654A Head-to-head Study Comparing the Functional Value of Two Models of Robotically Assisted Rehabilitation in SMA (Spinal Muscular Atrophy) PatientsWiktor Dega University Orthopedic and Rehabilitation Hospital
- RECRUITINGNANCT05866419Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular AtrophyAlcyone Therapeutics, Inc
See all trials for Autosomal dominant adult-onset proximal spinal muscular atrophy →